The JAK2 46/1 haplotype: a marker of inappropriate myelomonocytic response to cytokine stimulation, leading to increased risk of inflammation, myeloid neoplasm, and impaired defense against infection?

समान संसाधन

• The JAK2 46/1 haplotype predisposes to MPL-mutated myeloproliferative neoplasms
  द्वारा: Jones, Amy V., और अन्य
  प्रकाशित: (2010)
• The JAK2 GGCC (46/1) Haplotype in Myeloproliferative Neoplasms: Causal or Random?
  द्वारा: Anelli, Luisa, और अन्य
  प्रकाशित: (2018)
• The Hepatocyte Growth Factor (HGF)/Met Axis: A Neglected Target in the Treatment of Chronic Myeloproliferative Neoplasms?
  द्वारा: Boissinot, Marjorie, और अन्य
  प्रकाशित: (2014)
• Evaluation of the association between the JAK2 46/1 haplotype and chronic myeloproliferative neoplasms in a Brazilian population
  द्वारा: Silva, Sarah Pagliarini- e-, और अन्य
  प्रकाशित: (2013)
• Genetic Pathways Leading to Therapy-Related Myeloid Neoplasms
  द्वारा: Stoddart, Angela, और अन्य
  प्रकाशित: (2011)